Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Future Planet Capital is an impact-led venture capital and private equity firm founded in 2015. It focuses on investing in high-growth companies emerging from top universities and research centers globally. The firm's investments target global challenges aligned with the UN Sustainable Development Goals—specifically climate change, education, health, security, and sustainable growth. With over $400 million under management and more than 100 portfolio companies across multiple funds and geographies, FPC has been involved as an early investor in several notable companies including Vaccitech and 23andMe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Future Planet Capital.